The Korean Genetic Diagnosis Program for Rare Disease Phase II: outcomes of a 6-year national project

被引：2

作者：

Kim, Man Jin ^{[1
]}

Kim, Boram ^{[2
]}

Lee, Heerah ^{[2
]}

Lee, Jee-Soo ^{[2
]}

Chae, Seung Won ^{[2
,3
]}

Shin, Ho Seob ^{[2
]}

Cho, Sung Im ^{[2
]}

Kim, Soo Yeon ^{[4
]}

Moon, Jangsup ^{[1
]}

Lim, Byung Chan ^{[4
]}

Ko, Jung Min ^{[4
]}

Chae, Jong-Hee ^{[1
,4
]}

Park, Sung Sup ^{[2
]}

Seong, Moon-Woo ^{[2
]}

机构：

[1] Seoul Natl Univ Hosp, Dept Genom Med, Seoul, South Korea

[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Lab Med, Coll Med, Seoul, South Korea

[3] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea

[4] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pediat, Coll Med, Seoul, South Korea

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷 / 10期

关键词：

GUIDELINES;

D O I：

10.1038/s41431-023-01415-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The Korean Genetic Diagnosis Program for Rare Disease (KGDP) enrolled 1890 patients with rare diseases between March 2017 and October 2022. Children and adolescents accounted for the majority of the patients, and systemic disease was the most common presenting symptom. The exome-based virtual disease-specific multigene panel was the most frequently used analytical method, with an overall diagnostic yield of 33.3%. A total of 629 positive cases were diagnosed, involving 297 genes. All 297 genes identified in these cases were confirmed to be known genes listed in the OMIM database. The nationwide KGDP network and its cooperation with the Korean Undiagnosed Diseases Program (KUDP) provide a more comprehensive genetic analysis of undiagnosed cases. The partnership between the KGDP and KUDP has the potential to improve the diagnosis and treatment options for patients. In conclusion, KGDP serves as the primary access point or gateway to KUDP.

引用

页码：1147 / 1153

页数：7

共 50 条

[31] RE: Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia
Al-Mendalawi, Mahmood Dhahir
ANNALS OF SAUDI MEDICINE, 2011, 31 (06) : 661 - 661
[32] Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study
Ikonomidis, Ignatios
Athanassopoulos, George
Stamatelopoulos, Kimon
Lekakis, John
Revela, Ioanna
Venetsanou, Kiriaki
Marinou, Margarita
Monaco, Claudia
Cokkinos, Dennis V.
Nihoyannopoulos, Petros
AMERICAN HEART JOURNAL, 2008, 156 (02) : 269 - 276
[33] Incidental Diagnosis of Inflammatory Bowel Disease in a British Bowel Cancer Screening Cohort: 6-Year Clinical Outcome Follow-Up of the First Reported Cohort
Scott, Jennifer A.
Nosegbe, Uche
Butcher, Rhys O.
Abbasi, Atta M.
Prudham, Roger C.
George, Regi
Limdi, Jimmy K.
GASTROENTEROLOGY, 2016, 150 (04) : S396 - S396
[34] Clinical value of gated myocardial perfusion scintigraphy (gMPS) in type II diabetic patients with suspected or known coronary artery disease: A 6-year prognostic study
Cittanti, Corrado
Leonelli, Emanuela Succi
Acampa, Wanda
Giganti, Melchiore
Peterle, Chiara
De Cristofaro, Valentina
Panareo, Stefano
Prandini, Napoleone
Cuocolo, Alberto
Feggi, Luciano
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[35] Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial
Iwata, H.
Masuda, N.
Yamamoto, Y.
Fujisawa, T.
Toyama, T.
Taira, N.
Kashiwaba, M.
Ohtani, S.
Sakai, T.
Hasegawa, Y.
Nakamura, R.
Akabane, H.
Shibahara, Y.
Sasano, H.
Yamaguchi, T.
Ohashi, Y.
ANNALS OF ONCOLOGY, 2018, 29 : 58 - 58
[36] RE: Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia Reply
Moravej, Hossein
ANNALS OF SAUDI MEDICINE, 2011, 31 (06) : 662 - 662
[37] Incidental diagnosis of inflammatory bowel disease in a British bowel cancer-screening cohort: 6-year clinical outcome follow-up of the first reported cohort
Scott, J.
Nosegbe, U.
Butcher, R.
Abbassi, A.
Prudham, R.
George, R.
Limdi, J.
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S219 - S220
[38] THE INTERDICTION PROJECT: AN INNOVATIVE PROGRAM FOR HIV+ PERSONS TO REDUCE HIV AND STD CO-INFECTION AND IMPROVE HIV TREATMENT OUTCOMES PHASE II
Frimpong, S.
Wilson, M.
Mitchell-Samon, L. M.
Azarian, T.
SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A352 - A353
[39] Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study
Vieira, Ricardo D.
Pereira, Alexandre C.
Lima, Eduardo G.
Garzillo, Cibele L.
Rezende, Paulo Cury
Favarato, Desiderio
Hueb, Alexandre C.
Gersh, Bernard J.
Ramires, Jose A. F.
Hueb, Whady
CORONARY ARTERY DISEASE, 2012, 23 (02) : 79 - 84
[40] Cancer related death among different treatment options in chronic coronary artery disease: results from 6-year follow-up period of the MASS II trial
Vieira, R. D.
Pereira, A. C.
Soares, P. R.
Lima, E. G.
Garzillo, C. L.
Rezende, P. C.
Hueb, A. C.
Stolf, N. A. G.
Ramires, J. A. F.
Hueb, W.
EUROPEAN HEART JOURNAL, 2011, 32 : 568 - 569

← 1 2 3 4 5 →